Press "Enter" to skip to content

New patent for Galderma Labs drug MIRVASO

0
Copyright © DrugPatentWatch. Originally published at New patent for Galderma Labs drug MIRVASO

Annual Drug Patent Expirations for MIRVASO
Annual Drug Patent Expirations for MIRVASO

Mirvaso is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug and one Paragraph IV challenge.

MIRVASO drug price trends.

Drug patent litigation for MIRVASO.

This drug has ninety-one patent family members in thirty countries.

The generic ingredient in MIRVASO is brimonidine tartrate. One supplier is listed for this compound. Additional details are available on the brimonidine tartrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Galderma Labs drug MIRVASO
    Do NOT follow this link or you will be banned from the site!